Genomics

All articles by Genomics

Sangamo Therapeutics faces setbacks as Novartis and Biogen collaborations come to an end
Sangamo Therapeutics faces setbacks as Novartis and Biogen collaborations come to an end
Jack O'Brien
March 21, 2023
11:58 am

Going forward, Sangamo said it will continue to investigate alternative options to advance these programs, including either internally or with another collaboration partner.

Five things for pharma marketers to know: Friday, December 8, 2017
Five things for pharma marketers to know: Friday, December 8, 2017
Virginia Lau
December 8, 2017
3:20 pm

FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance

Five things for pharma marketers to know: Thursday, June 29, 2017
Five things for pharma marketers to know: Thursday, June 29, 2017
Virginia Lau
June 29, 2017
2:30 pm

Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition

Brandi Davis-Dusenbery, Seven Bridges
Brandi Davis-Dusenbery, Seven Bridges
April 4, 2017
11:00 am

Brandi Davis-Dusenbery is CEO of Seven Bridges.

Five things for pharma marketers to know: Tuesday, January 10, 2017
Five things for pharma marketers to know: Tuesday, January 10, 2017
Virginia Lau
January 10, 2017
3:27 pm

Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet’s opioid Arymo ER gets FDA approval

Five things for pharma marketers to know: Tuesday, November 22, 2016
Five things for pharma marketers to know: Tuesday, November 22, 2016
Virginia Lau
November 22, 2016
2:37 pm

Intarcia submits diabetes drug-delivery pump for FDA approval; Shire to build rare-disease innovation hub; AstraZeneca to resume durvalumab trials

Five things for pharma marketers to know: Friday, April 22, 2016
Five things for pharma marketers to know: Friday, April 22, 2016
Jaimy Lee
April 22, 2016
2:30 pm

AstraZeneca to sequence two million genomes; Valeant considering Perrigo CEO as its new chief executive; AMA and PhRMA each spent $6 million on lobbying

Clinton tells pharma to explain drug prices
Clinton tells pharma to explain drug prices
Barbara Peck
June 16, 2015
6:00 pm

Speakers at Klick Health’s event criticized, lauded the role of technology in healthcare.

  • From Our Partners